✦ LIBER ✦

Incidence, clinical features, laboratory findings and outcome of patients with multiple myeloma presenting with extramedullary relapse

✍ Scribed by Papanikolaou, Xenofon; Repousis, Panagiotis; Tzenou, Tatiana; Maltezas, Dimitris; Kotsopoulou, Maria; Megalakaki, Katerina; Angelopoulou, Maria; Dimitrakoloulou, Elektra; Koulieris, Efstathios; Bartzis, Vassiliki; Pangalis, Gerasimos; Panayotidis, Panagiotis; Kyrtsonis, Marie-Christine

Book ID: 120494426
Publisher: Informa plc
Year: 2012
Tongue: English
Weight: 221 KB
Volume: 54
Category: Article
ISSN: 1042-8194
DOI: 10.3109/10428194.2012.746683

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Reduced-intensity conditioning allogenei

Reduced-intensity conditioning allogeneic transplantation is associated with a high incidence of extramedullary relapses in multiple myeloma patients

✍ Pérez-Simón, J A; Sureda, A; Fernández-Aviles, F; Sampol, A; Cabrera, J R; Cabal 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 92 KB

Incidence of extramedullary disease in p

Incidence of extramedullary disease in patients with multiple myeloma in the era of novel therapy, and the activity of pomalidomide on extramedullary myeloma

✍ Short, K Detweiler; Rajkumar, S V; Larson, D; Buadi, F; Hayman, S; Dispenzieri, 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 163 KB

Clinical analysis of 36 multiple myeloma

Clinical analysis of 36 multiple myeloma patients with extramedullary plasmacytoma invasion of the spinal canal

✍ Zhang, Jiajia; Zhong, Yuping 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 174 KB

Extramedullary (EMP) relapse in unusual

Extramedullary (EMP) relapse in unusual locations in multiple myeloma: Is there an association with precedent thalidomide administration and a correlation of special biological features with treatment and outcome?

✍ E. Katodritou; V. Gastari; E. Verrou; C. Hadjiaggelidou; M. Varthaliti; S. Georg 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 186 KB

Extramedullary relapse constitutes an uncommon manifestation of multiple myeloma (MM), characterized by highly malignant histology, special biological features, resistance to treatment and poor outcome. Its incidence has been increased during the last years, probably due to the introduction of novel

Bortezomib and dexamethasone as salvage

Bortezomib and dexamethasone as salvage therapy in patients with relapsed/refractory multiple myeloma: analysis of long-term clinical outcomes

✍ Lucia Pantani, Elena Zamagni, Beatrice Anna Zannetti… 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 184 KB

P.10.11 CLINICAL FEATURES AND OUTCOME OF

P.10.11 CLINICAL FEATURES AND OUTCOME OF PANCREATIC ADENOCARCINOMA PATIENTS PRESENTING WITH CACHEXIA

✍ Piciucchi, M.; Valente, R.; Larghi, A.; Stigliano, S.; Archibugi, L.; Signoretti 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 73 KB